Hims & Hers Health, Inc.
HIMS- Exchange
- NYSE
- Industry
- Services-Offices & Clinics of Doctors of Medicine
- SEC CIK
- 0001773751
In the last 90 days, Hims & Hers Health, Inc. insiders filed 0 open-market purchases and 14 sales; 511 institutions reported holding it in 13F filings for Q2 2026, worth $5.39B in total; no superinvestor holds it.
Key figures
- Market capNo recent share count in SEC filings
- –
- Insider buysOpen market, last 90 days
- 0
- Insider sellsLast 90 days, $6.00M in total
- 14
- 13F holdersQ2 2026, +79 vs. previous quarter
- 511
- 13F valueReported value at the end of Q2 2026
- $5.39B
- Superinvestors holdingAt the end of Q2 2026
- 0
Price chart
Financials
See financial statementsFrom SEC filings, in USD.
- Revenue, FY2025
- $2.35B
- +59.0% year over year
- Net income, FY2025
- $128.4M
- +1.8% year over year
- Free cash flow, FY2025
- $57.4M
- −71.0% year over year
- Revenue, Q3 FY2026
- $890.4M
- +48.6% year over year
Revenue flow, FY2025
Green is profit; orange is costs, expenses and taxes. Percentages are shares of revenue.
Short interest
See short dataFrom FINRA, settlement date Oct 30, 2026.
- Short interest
- 51.7M
- Shares sold short
- Change
- −1.82M
- −3.4% vs. previous
- Days to cover
- 5.84
- At average daily volume
Superinvestors holding HIMS, Q2 2026
Go to the superinvestors tabNo superinvestor reported holding HIMS at the end of Q2 2026.
Latest insider trades
See all insider tradesOpen-market purchases and sales by Hims & Hers Health, Inc. insiders from Form 4, newest first.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Oct 29, 2026 (view filing)4:11 PM ET | Oct 28 | 1 day | Boughton SoleilChief Legal Officer | SSaleClass A Common Stock | −3.46K | $27.60 | −$95.6K | −1.2%293.9K after | 10b5-1 |
| Oct 15, 2026 (view filing)4:44 PM ET | Oct 14 | 1 day | Boughton SoleilChief Legal Officer | SSaleClass A Common Stock | −3.46K | $29.06 | −$100.6K | −1.2%297.3K after | 10b5-1 |
| Oct 2, 2026 (view filing)4:32 PM ET | Oct 1 | 1 day | Okupe OluyemiChief Financial Officer | SSaleClass A Common Stock | −2.00K | $29.70 | −$59.4K | −0.8%234.5K after | 10b5-1 |
| Oct 2, 2026 (view filing)4:31 PM ET | Sep 30 | 2 days | Boughton SoleilChief Legal Officer | SSaleClass A Common Stock | −3.46K | $29.17 | −$101.0K | −1.1%300.8K after | 10b5-1 |
| Sep 23, 2026 (view filing)4:17 PM ET | Sep 22 | 1 day | Okupe OluyemiChief Financial Officer | SSaleClass A Common Stock | −29.3K | $29.95 | −$876.8K | −11.0%236.5K after | 10b5-1 |
| Sep 18, 2026 (view filing)4:17 PM ET | Sep 17 | 1 day | Okupe OluyemiChief Financial Officer | SSaleClass A Common Stock | −12.3K | $28.82 | −$354.9K | −4.7%251.8K after | 10b5-1 |
| Sep 17, 2026 (view filing)4:17 PM ET | Sep 16 | 1 day | Boughton SoleilChief Legal Officer | SSaleClass A Common Stock | −6.24K | $27.86 | −$173.7K | −2.0%304.3K after | 10b5-1 |
| Sep 17, 2026 (view filing)4:17 PM ET | Sep 15 | 2 days | Chi MichaelChief Operating Officer | SSaleClass A Common Stock | −14.0K | $28.39 | −$398.2K | −3.0%456.7K after | 10b5-1 |
| Sep 17, 2026 (view filing)4:17 PM ET | Sep 15 | 2 days | Elshenawy MohamedCTO | SSaleClass A Common Stock | −7.95K | $28.39 | −$225.8K | −4.1%185.6K after | 10b5-1 |
| Sep 3, 2026 (view filing)4:31 PM ET | Sep 2 | 1 day | Boughton SoleilChief Legal Officer | SSaleClass A Common Stock | −3.46K | $28.33 | −$98.0K | −1.1%310.5K after | 10b5-1 |
Top 10 13F holders, Q2 2026
See all 511 holdersThe largest institutional positions in Hims & Hers Health, Inc. at the end of Q2 2026; share changes are against Q1 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| BlackRock, Inc. | 28,703,514 | $995.2M | 0.01% | +2,366,356+9.0% | Added |
| Vanguard Portfolio Management LLC | 10,559,314 | $366.1M | 0.02% | +375,501+3.7% | Added |
| Vanguard Capital Management LLC | 9,541,384 | $330.8M | 0.01% | +201,673+2.2% | Added |
| State Street Corp | 8,145,699 | $282.4M | 0.01% | +685,676+9.2% | Added |
| Morgan Stanley | 7,152,498 | $248.0M | 0.01% | −1,736,590−19.5% | Reduced |
| Divisadero Street Capital Management, LP | 6,009,505 | $208.3M | 4.86% | +5,539,672+1,179.1% | Added |
| Geode Capital Management, LLC | 5,681,832 | $197.0M | 0.01% | +483,053+9.3% | Added |
| Goldman Sachs Group Inc | 5,173,865 | $179.4M | 0.02% | +2,719,170+110.8% | Added |
| JPMorgan Chase & Co | 4,766,781 | $159.5M | 0.01% | −474,035−9.0% | Reduced |
| FMR LLC | 4,323,292 | $149.9M | 0.01% | +4,230,022+4,535.2% | Added |
Holders of 5% or more of HIMS
See all 3 holders and filingsHolders whose latest Schedule 13D or 13G filing reports 5% or more of Hims & Hers Health, Inc..
| Holder | Latest form | Stake | Change | First filed | Latest filing | Filing |
|---|---|---|---|---|---|---|
| BlackRock, Inc. | 13G/A | 11.90%26.5M shares | +1.10 ppfrom 10.80% | Oct 22, 20244 filings | Jul 28, 2026 | SEC |
| Dudum Andrew | 13D/A | 9.40%22.6M shares | −0.90 ppfrom 10.30% | Feb 1, 20215 filings | Aug 31, 2026 | SEC |
| Susquehanna Securities, LLC | 13G | 6.50%14.5M shares | New | May 15, 20261 filing | May 15, 2026 | SEC |
Politician trades
All politician trades in HIMS1 member of Congress reported 1 trade in Hims & Hers Health, Inc. since 2020. Newest filings:
| Filed | Politician | Type | Amount |
|---|---|---|---|
| Sep 12, 2025 | Lisa C. McClain House · MI | Buy | $1K-$15K |

House · MI · Sep 12, 2025
Buy$1K-$15K